We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

101 hedge funds and large institutions have $167M invested in Immunomedics Inc in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 29 increasing their positions, 33 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more call options, than puts

Call options by funds: $6.99M | Put options by funds: $3.65M

39% more capital invested

Capital invested by funds: $120M → $167M (+$46.9M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less funds holding

Funds holding: 110 → 101 (-9)

12% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 33

53% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 15

Holders
101
Holders Change
-9
Holders Change %
-8.18%
% of All Funds
2.69%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
7
Increased
29
Reduced
33
Closed
15
Calls
$6.99M
Puts
$3.65M
Net Calls
+$3.34M
Net Calls Change
+$710K

Top Buyers

Rank Fund Capital Flow
1
JGC
J. Goldman & Co
New York
+$4.74M
2
NC
Nexthera Capital
New York
+$3.53M
3
Millennium Management
Millennium Management
New York
+$2.85M
4
GTC
Ghost Tree Capital
New York
+$2.8M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$1.33M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$4.11M
2
ACA
Avoro Capital Advisors
New York
-$3.39M
3
Deutsche Bank
Deutsche Bank
Germany
-$2.63M
4
State Street
State Street
Massachusetts
-$2.58M
5
ACP
Acuta Capital Partners
California
-$979K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$1.15M +$10.7K +3,810 +1%
PVI
27
Pura Vida Investments
New York
$1.04M +$567K +202,822 +174%
B
28
Bailard
California
$1.02M – – –
SM
29
Sabby Management
Florida
$966K -$357K -127,690 -30%
Arrowstreet Capital
30
Arrowstreet Capital
Massachusetts
$958K +$824K +294,656 New
BCM
31
Bridgeway Capital Management
Texas
$939K – – –
Wells Fargo
32
Wells Fargo
California
$719K -$18K -6,446 -3%
CEP
33
Chicago Equity Partners
Illinois
$667K +$264K +94,285 +85%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$648K -$360K -128,888 -39%
Charles Schwab
35
Charles Schwab
California
$641K – – –
AllianceBernstein
36
AllianceBernstein
Tennessee
$603K – – –
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$599K +$3.63K +1,300 +0.7%
TA
38
Teachers Advisors
New York
$554K – – –
IA
39
IFP Advisors
Florida
$530K – – –
Swiss National Bank
40
Swiss National Bank
Switzerland
$473K – – –
SW
41
SVB Wealth
Massachusetts
$471K – – –
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$415K -$24.9K -8,900 -7%
BA
43
BlackRock Advisors
Delaware
$386K +$207K +74,168 +165%
T. Rowe Price Associates
44
T. Rowe Price Associates
Maryland
$368K +$224K +80,000 +242%
Goldman Sachs
45
Goldman Sachs
New York
$353K -$116K -41,312 -28%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$315K -$52.9K -18,930 -16%
CS
47
Credit Suisse
Switzerland
$306K -$93.5K -33,452 -26%
State Board of Administration of Florida Retirement System
48
State Board of Administration of Florida Retirement System
Florida
$303K – – –
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$286K – – –
VEA
50
Virtus ETF Advisers
New York
$263K – – –
1
2
3 4 5

IMMU Hedge Fund Activity: Q3 2016 in Review

101 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2016, worth a combined $167M — up 39% from $120M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of IMMU and 7 opened new positions — a net loss of 8 holders — while 33 trimmed existing stakes and 29 added.

The largest buyer was J. Goldman & Co, opening a new position worth an estimated $4.74M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $4.11M sold.

  • 101 institutional investors held Immunomedics Inc (IMMU) as of Q3 2016, down from 110 in Q2 2016.
  • Funds reported $167M of Immunomedics Inc stock for Q3 2016, up 39% quarter-over-quarter.
  • 7 funds opened new Immunomedics Inc positions in Q3 2016 and 15 closed out, a net change of -8 holders.
  • The largest Immunomedics Inc buyer in Q3 2016 was J. Goldman & Co, an estimated $4.74M added.
  • The largest Immunomedics Inc seller in Q3 2016 was Renaissance Technologies, an estimated $4.11M sold.

Based on aggregated 13F filings for Q3 2016.